Chretien's life work began while he was a doctoral student at Berkeley in the 1960s. His seminal paper, published in the Canadian Journal of Biochemistry in 1967, pointed out patterns in the cleavage sites in precursors of many of the specialized molecules the body needs to function. He suggested the existence of convertases, which are enzymes that split large proteins into the crucial chemicals of life, such as insulin, endorphins and growth factors. An understanding of these enzymes forms not only a basis to fundamental metabolic processes, but suggests new insights into natural processes such as aging, and the pathologies of cancer, atherosclerosis, hypertension, obesity, epilepsy, psoriasis and AIDS.
The next step was to find the enzymes that act as convertases. Starting in 1967, as Director and later as Scientific Director, Chretien led a team at the Biochemical Neuroendocrinology laboratory of the Clinical Research Institute of Montreal (CRIM) in this endeavor. He was joined by Dr. Nabil G. Seidah in 1974. It was not until 1990 that a new technology allowed the team to actually discover convertases. PCR, or polymer chain reaction, is a means whereby DNA molecules can be synthesized and amplified using known strings of amino acids. Using this technology, the team was able to identify the characteristics of seven of the eight mammalian convertases known thus far.
Image by: Freelance Illustration
Under Chretien's scientific directorship, the research facilities at CRIM expanded rapidly, growing to include research programs in molecular biology, molecular genetics, immunology, neurobiology, and brain chemistry. His studies on convertases ranged widely, including topics such as their effects on tumours and their role in brain development in the unborn child.
In 1998, Chretien joined the Ottawa Civic Hospital Loeb Research Institute as CEO and scientific director. There he founded the Diseases of Aging Centre, where he continues his collaborations with his colleagues from CRIM. At present, he is applying his knowledge of convertases to an investigation of diseases that accelerate the aging process, such as diabetes, obesity, AIDS and Alzheimer's.
Dr. Chretien is the recipient of many degrees and honours for his pioneering research.
Sources: Ottawa Health Research Institute; Research Matters, Vol. 3, No. 1, Winter 1998, Molecules & Medicine, Vol 1 No 2 Fall 1999. Photo: Government of Quebec.
- March 26, 1936
- Shawinigan, Quebec
- Family Members
- Wife: Micheline
- Brother: Jean Chrétien, Prime Minister of Canada
- Parents: Marie and Willie Chrétien
- Professor; Program Director and Senior Scientist, Diseases of Aging, Ottawa Health Research Institute
- Department of Medicine, University of Ottawa
- BA (<i>Cum Laude</i>) University of Montreal, 1955
- MD (<i>Cum Laude</i>) University of Montreal, 1960
- MSc, McGill University, 1962
- CSPQ (Endocrinology), Corporation Professionnelle des Mèdecins du Quèbec, 1969
- Henry Friesen Award, 1999
- PMAC Medal of Honor, 1999
- Officer, National Order of Québec, 1994
- Manning Award of Distinction, 1994
- Officer, Order of Canada, 1986
- Izaak Walton Killam Memorial Prize
- Médaille du Mérite exceptionel, Clinical Research Institute of Montreal
- McLaughlin Medal, Royal Society of Canada
- Prix de l'Oeuvre Scientifique, Association des Médecins de Langue Française du Canada
- Award from the Clarke Institute of Psychiatry, Toronto
- Michel Sarrazin Award, Club de Recherches Cliniques
- Marcel Piché Award, Clinical Research Institute of Montreal
- Boehringer-Mannheim Award, Canadian Society of Biochemistry and Molecular Biology
- Distinguished Service Award from the Canadian Society of Endocrinology and Metabolism
- Fundamental Research Award, Association des Médecins de Langue Française du Canada
- Medal of the Royal College of Physicians and Surgeons of Canada
- Last Updated
- June 17, 2015
Profile viewed 29245 times
Other scientists who may be of interest: